Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.

L Zhang, W J Blot, W C You, Y S Chang, R W Kneller, M L Jin, J Y Li, L Zhao, W D Liu, J S Zhang, J L Ma, I M Samloff, P Correa, M J Blaser, G W Xu and J F Fraumeni Jr
L Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W J Blot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W C You
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y S Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R W Kneller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M L Jin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Y Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Zhao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W D Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J S Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J L Ma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I M Samloff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Correa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M J Blaser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G W Xu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J F Fraumeni Jr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published August 1996
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Helicobacter pylori infection is a major cause of gastritis and may be a key risk factor for stomach cancer, but its role in the process of gastric carcinogenesis is not well understood. Herein, we examine H. pylori prevalence in relation to demographic and lifestyle factors and to severity of precancerous lesions in an area of China with one of the highest rates of stomach cancer in the world. H. pylori serum IgG antibody positivity was assayed among 2646 adults, ages 35-64, participating in a population-based gastroscopic screening survey in the high-risk area. The prevalence of positivity was evaluated according to gastric histology, environmental and lifestyle variables determined by interviews during the screening, and level of serum pepsinogens. The odds of advanced precancerous lesions (intestinal metaplasia and dysplasia) of the stomach among those with antibody positivity were estimated by logistic regression. Seventy-two % of the population was H. pylori antibody-positive, with nonsignificant variation by sex, age, income, education, family size, and cigarette smoking habits. H. pylori positivity was higher among those who ate sour pancakes, a fermented indigenous staple that is a risk factor for gastric dysplasia and stomach cancer in this population. The prevalence of H. pylori varied most notably, however, with gastric pathology. The percent of H. pylori positivity increased from 55 to 60 to 87% among those with superficial (nonatrophic) gastritis, mild chronic atrophic gastritis, and severe chronic atrophic gastritis, respectively, before falling to 78% among those with intestinal metaplasia or dysplasia. H. pylori antibody positivity also was strongly correlated with serum pepsinogen concentrations, particularly pepsinogen II, but knowledge of H. pylori status did not markedly improve serological identification of advanced precancerous lesions above that provided by pepsinogen ratios alone. The findings suggest that H. pylori infection contributes to the process of gastric carcinogenesis, particularly during the early stages, in this high-risk area.

PreviousNext
Back to top
August 1996
Volume 5, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
L Zhang, W J Blot, W C You, Y S Chang, R W Kneller, M L Jin, J Y Li, L Zhao, W D Liu, J S Zhang, J L Ma, I M Samloff, P Correa, M J Blaser, G W Xu and J F Fraumeni Jr
Cancer Epidemiol Biomarkers Prev August 1 1996 (5) (8) 627-630;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
L Zhang, W J Blot, W C You, Y S Chang, R W Kneller, M L Jin, J Y Li, L Zhao, W D Liu, J S Zhang, J L Ma, I M Samloff, P Correa, M J Blaser, G W Xu and J F Fraumeni Jr
Cancer Epidemiol Biomarkers Prev August 1 1996 (5) (8) 627-630;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement